Ignite Creation Date:
2024-05-06 @ 7:55 PM
Last Modification Date:
2024-10-26 @ 3:17 PM
Study NCT ID:
NCT06187961
Status:
RECRUITING
Last Update Posted:
2024-01-03
First Post:
2023-12-08
Brief Title:
Combined HAIC Lenvatinib and Cadonilimab As Conversion Therapy for Unresectable Hepatocellular Carcinoma
Sponsor:
Tongji Hospital
Organization:
Tongji Hospital
Organization Data
Organization:
Tongji Hospital
Class:
OTHER
Study ID:
2023-S039
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Tongji Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
Ze-yang Ding MD
Responsible Party Title:
Prof
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Tongji Hospital
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Geneplus-Beijing Co Ltd | INDUSTRY |